spbmedicalrecordsНовые Санкт-Петербургские врачебные ведомостиNew St. Petersburg Medical Records1609-2201Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова10.24884/1609-2201-2024-103-1-33-41spbmedicalrecords-5Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSАтеросклеротическая реноваскулярная болезнь: патогенез, клинические проявления, диагностика, лечение. Обзор литературыAtherosclerotic renovascular disease: pathogenesis, clinical manifestations, diagnosis, treatment. Literature reviewhttps://orcid.org/0000-0002-8788-0076БарановаЕ. И.BaranovaE. I.

Баранова Елена Ивановна, доктор медицинских наук, профессор кафедры терапии факультетской с курсом эндокринологии, кардиологии с клиникой им. акад. Г. Ф. Ланга

197022, Санкт-Петербург, ул. Льва толстого, д. 6-8

Baranova Elena I., MD, PhD, DSc, Professor, Department of Faculty Therapy

6-8, L’va Tolstogo str., Saint Petersburg, 197022

baranova.grant2015@yandex.ruhttps://orcid.org/0000-0003-2698-7977КацапА. А.KatsapA. A.

Кацап Анна Александровна, кандидат медицинских наук, доцент кафедры терапии факультетской с курсом эндокринологии, кардиологии с клиникой им. акад. Г. Ф. Ланга

197022, Санкт-Петербург, ул. Льва толстого, д. 6-8

Katsap Anna A., MD, PhD, Assistant Professor, Department of Faculty Therapy

6-8, L’va Tolstogo str., Saint Petersburg, 197022

annakatsap@inbox.ruhttps://orcid.org/0000-0002-0668-2490КолесникО. С.KolesnikO. S.

Колесник Ольга Степановна, кандидат медицинских наук, доцент кафедры терапии факультетской с курсом эндокринологии, кардиологии с клиникой им. акад. Г.Ф. Ланга

197022, Санкт-Петербург, ул. Льва толстого, д. 6-8

Kolesnik Olga S., PhD, Assistant Professor, Department of Faculty Therapy

6-8, L’va Tolstogo str., Saint Petersburg, 197022

oleskol@inbox.ruФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова» Министерства здравоохранения Российской ФедерацииРоссияPavlov UniversityRussian Federation202419082024013341Copyright © Баранова Е.И., Кацап А.А., Колесник О.С., 20242024Баранова Е.И., Кацап А.А., Колесник О.С.Baranova E.I., Katsap A.A., Kolesnik O.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.docved.ru/jour/article/view/5

Обзор литературы посвящен одной из наиболее частых вторичных форм артериальных гипертензий – реноваскулярной гипертензии атеросклеротического генеза. В обзоре рассматриваются патогенетические механизмы, факторы риска и клинические проявления данной патологии, ее распространенность. Особое внимание уделяется проблеме сочетания реноваскулярной артериальной гипертензии с дисфункцией почек и с проявлениями сердечной недостаточности, что наиболее характерно для двусторонних гемодинамически значимых стенозов или резко выраженного стеноза единственной функционирующей почки, и позволяет сформулировать представление об атеросклеротической реноваскулярной болезни. В обзоре содержатся современные представления о диагностике этого заболевания и тактике ведения больных с данной патологией. Особое внимание уделяется показаниям для реваскуляризации и способам восстановления кровотока по почечным артериям. В обзоре подробно обсуждаются проблемы ведения больных после интервенционного лечения и прогноз пациентов с атеросклеротической реноваскулярной болезнью.

The literature review is devoted to one of the most common secondary forms of arterial hypertension – renovascular hypertension of atherosclerotic genesis. The review examines the prevalence of this problem, pathogenetic mechanisms, risk factors and clinical manifestations. Special attention should be paid to the problem of combining renovascular arterial hypertension with renal dysfunction and with manifestations of heart failure, which is most typical for bilateral hemodynamically significant stenoses or significant stenosis of a single functioning kidney, and allows us to formulate an idea of atherosclerotic renovascular disease. The review contains modern ideas about the diagnosis of this disease and the tactics of managing patients with this pathology. Special attention should be paid to indications for revascularization and ways to restore blood flow through the renal arteries. The review discusses in detail the problems of patient management after interventional treatment and the prognosis of patients with atherosclerotic renovascular disease.

реноваскулярная артериальная гипертензияатеросклерозреваскуляризацияrenovascular arterial hypertensionatherosclerosisrevascularizationReferencesHansen K.J., Edwards M.S., Craven T.E. et al. Prevalence of renovascular disease in the elderly: A population-based study. ‒ J Vasc Surg. ‒ 2002. ‒ 36. ‒ 443–451. DOI: 10.1067/mva.2002.127351.Hansen K.J., Edwards M.S., Craven T.E. et al. Prevalence of renovascular disease in the elderly: A population-based study. J Vasc Surg. 2002;36:443–451. DOI: 10.1067/mva.2002.127351.Benjamin M.M., Fazel P., Filardo G. et al. Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension. ‒ Am J Cardiol. ‒ 2014. ‒ 113. ‒ 687–690. DOI: 10.1016/J.AMJCARD.2013.10.046.Benjamin M.M., Fazel P., Filardo G. et al. Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension. Am J Cardiol. 2014;113:687–690. DOI: 10.1016/J.AMJCARD.2013.10.046.De Mast Q., Beutler J.J. The prevalence of atherosclerotic renal artery stenosis in risk groups: A systematic literature review. ‒ J Hypertens. ‒ 2009. ‒ 27. ‒ 1333–1340. DOI: 10.1097/HJH.0b013e328329bbf4.De Mast Q., Beutler J.J. The prevalence of atherosclerotic renal artery stenosis in risk groups: A systematic literature review. J Hypertens. 2009;27:1333–1340. DOI: 10.1097/HJH.0b013e328329bbf4.de Silva R., Loh H., Rigby A.S. et al. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. American Journal of Cardiology. ‒ 2007. ‒ 100. ‒ 273–279. DOI: 10.1016/j.amjcard.2007.02.098.de Silva R., Loh H., Rigby A.S. et al. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. American Journal of Cardiology. 2007;100:273–279. DOI: 10.1016/j.amjcard.2007.02.098.Safian R.D., Textor S.C. Renal-artery stenosis. ‒ N Engl J Med. ‒ 2001. ‒ 344. ‒ 431–42. DOI:10.1056/NEJM200102083440607.Safian R.D., Textor S.C. Renal-artery stenosis. N Engl J Med. 2001;344:431–42. DOI:10.1056/NEJM200102083440607.Hicks C.W., Clark T.W.I., Cooper C.J. et al. Atherosclerotic renovascular disease: a KDIGO (Kidney Disease: Improving Global Outcomes) controversies conference. ‒ American Journal of Kidney Diseases. ‒ 2022. ‒ 79. ‒ 289–301. DOI: 10.1053/j.ajkd.2021.06.025.Hicks C.W., Clark T.W.I., Cooper C.J. et al. Atherosclerotic renovascular disease: a KDIGO (Kidney Disease: Improving Global Outcomes) controversies conference. American Journal of Kidney Diseases. 2022;79:289–301. DOI: 10.1053/j.ajkd.2021.06.025.Aoi W., Akahoshi M., Seto S. et al. Correction of hypertension by partial nephrectomy in segmental renal artery stenosis and electron microscopic studies of renin. ‒ Jpn Heart J. ‒ 1981. ‒ 22. ‒ 679–687. DOI: 10.1536/ihj.22.679.Aoi W., Akahoshi M., Seto S. et al. Correction of hypertension by partial nephrectomy in segmental renal artery stenosis and electron microscopic studies of renin. Jpn Heart J. 1981;22:679–687. DOI: 10.1536/ihj.22.679.Januszewicz A., Mulatero P., Dobrowolski P. et al. Cardiac phenotypes in secondary hypertension: JACC State-of-the-Art Review. ‒ J Am Coll Cardiol. ‒ 2022. ‒ 80. ‒ 1480–1497. DOI: 10.1016/j.jacc.2022.08.714.Januszewicz A., Mulatero P., Dobrowolski P. et al. Cardiac phenotypes in secondary hypertension: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;80:1480–1497. DOI: 10.1016/j.jacc.2022.08.714.Halimi J.M., Ribstein J., Du Cailar G., Mimran A. Nephrotic-range proteinuria in patients with renovascular disease. ‒ American Journal of Medicine. ‒ 2000. ‒ 108. ‒ 120–126. DOI: 10.1016/S0002-9343(99)00411-8.Halimi J.M., Ribstein J., Du Cailar G., Mimran A. Nephrotic-range proteinuria in patients with renovascular disease. American Journal of Medicine. 2000;108:120–126. DOI: 10.1016/S0002-9343(99)00411-8.Sarafidis P.A., Theodorakopoulou M., Ortiz A. et al. Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH). ‒ Nephrol Dial Transplant. ‒ 2023. ‒ 38. ‒ 2835–2850. DOI: 10.1093/NDT/GFAD095.Sarafidis P.A., Theodorakopoulou M., Ortiz A. et al. Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH). Nephrol Dial Transplant. 2023;38:2835–2850. DOI: 10.1093/NDT/GFAD095.Rimmer J.M., Gennari F.J. Atherosclerotic renovascular disease and progressive renal failure. ‒ Ann Intern Med. ‒ 1993. ‒ 118. ‒ 712–719. DOI:10.7326/0003-4819-118-9-199305010-00010.Rimmer J.M., Gennari F.J. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med.1993;118:712–719. DOI:10.7326/0003-4819-118-9-199305010-00010.Soulez G., Therasse E., Qanadli S.D. et al. Prediction of clinical response after renal angioplasty: Respective value of renal Doppler sonography and scintigraphy. ‒ American Journal of Roentgenology. ‒ 2003. ‒ 181. ‒ 1029–1035. DOI: 10.2214/ajr.181.4.1811029.Soulez G., Therasse E., Qanadli S.D. et al. Prediction of clinical response after renal angioplasty: Respective value of renal Doppler sonography and scintigraphy. American Journal of Roentgenology. 2003;181:1029–1035. DOI: 10.2214/ajr.181.4.1811029.McDonald J.S., McDonald R.J., Carter R.E. et al. Risk of intravenous contrast material-mediated acute kidney injury: A propensity score-matched study stratified by baseline-estimated glomerular filtration rate. ‒ Radiology. – 2014. ‒ 271. ‒ 65–73. DOI:10.1148/radiol.13130775.McDonald J.S., McDonald R.J., Carter R.E. et al. Risk of intravenous contrast material-mediated acute kidney injury: A propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology. 2014;271:65–73. DOI:10.1148/radiol.13130775.Woolen S.A., Shankar P.R., Gagnier J.J. et al. Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group ii gadolinium-based contrast agent: A systematic review and meta-analysis. ‒ JAMA Intern Med. ‒ 2020. ‒ 180. ‒ 223–230. DOI: 10.1001/jamainternmed.2019.5284.Woolen S.A., Shankar P.R., Gagnier J.J. et al. Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group ii gadolinium-based contrast agent: A systematic review and meta-analysis. JAMA Intern Med. 2020;180:223–230. DOI: 10.1001/jamainternmed.2019.5284.Klein A.J., Jaff M.R., Gray B.H. et al. SCAI appropriate use criteria for peripheral arterial interventions: An update. ‒ Catheterization and Cardiovascular Interventions. ‒ 2017. ‒ 90. ‒ E90–E110. DOI: 10.1002/ccd.27141.Klein A.J., Jaff M.R., Gray B.H. et al. SCAI appropriate use criteria for peripheral arterial interventions: An update. Catheterization and Cardiovascular Interventions.2017;90:E90–E110. DOI: 10.1002/ccd.27141.Losito A., Gaburri M., Errico R. et al. Survival of patients with renovascular disease and ACE inhibition. ‒ Clin Nephrol. ‒ 1999. ‒ 52. ‒ 339–343.Losito A., Gaburri M., Errico R. et al. Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol. 1999;52:339–343.Visseren F., Mach F., Smulders Y.M. et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. ‒ Eur Heart J. ‒ 2021. ‒ 42. ‒ 3227–3337. DOI: 10.1093/eurheartj/ehab484.Visseren F., Mach F., Smulders Y.M. et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–3337. DOI: 10.1093/eurheartj/ehab484.Ritchie J., Green D., Alderson H.V. et al. Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease. ‒ Journal of the American Society of Hypertension. ‒ 2016. ‒ 10. ‒ 149‒158.e3. DOI: 10.1016/j.jash.2015.12.002.Ritchie J., Green D., Alderson H.V. et al. Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease. Journal of the American Society of Hypertension. 2016;10:149‒158.e3. DOI: 10.1016/j.jash.2015.12.002.Van der Niepen P., Rossignol P., Lengelé J.P. et al. Renal artery stenosis in patients with resistant hypertension: Stent it or not? ‒ Curr Hypertens Rep. ‒ 2017. ‒ 19. ‒ 5. DOI: 10.1007/s11906-017-0703-8.Van der Niepen P., Rossignol P., Lengelé J.P. et al. Renal artery stenosis in patients with resistant hypertension: Stent it or not? Curr Hypertens Rep. 2017;19:5. DOI: 10.1007/s11906-017-0703-8.Pappaccogli M., Robberechts T., Lengelé J.P. et al. Endovascular versus medical management of atherosclerotic renovascular disease: Update and emerging concepts. ‒ Hypertension. ‒ 2023. ‒ 80. ‒1150–1161. DOI: 10.1161/HYPERTENSIONAHA.122.17965.Pappaccogli M., Robberechts T., Lengelé J.P. et al. Endovascular versus medical management of atherosclerotic renovascular disease: Update and emerging concepts. Hypertension. 2023;80:1150– 1161. DOI: 10.1161/HYPERTENSIONAHA.122.17965.Aboyans V., Ricco J.B., Bartelink M.L.E.L. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). ‒ Eur Heart J. 2018. ‒ 39. ‒ 763–816. DOI: 10.1093/eurheartj/ehx095.Aboyans V., Ricco J.B., Bartelink M.L.E.L. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018; 39:763–816. DOI: 10.1093/eurheartj/ehx095.Ivanovic V, McKusick MA, Johnson CM, et al. Renal artery stent placement: Complications at a single tertiary care center. Journal of Vascular and Interventional Radiology. 2003. ‒ 14. ‒ 217–225. DOI: 10.1097/01.RVI.0000058324.82956.2a.Ivanovic V, McKusick MA, Johnson CM, et al. Renal artery stent placement: Complications at a single tertiary care center. Journal of Vascular and Interventional Radiology. 2003;14:217–225. DOI: 10.1097/01.RVI.0000058324.82956.2a.Solomon R. Hydration: Intravenous and oral: Approaches, principals, and differing regimens: Is it what goes in or what comes out that is important? ‒ Interv Cardiol Clin. ‒ 2020. ‒ 9. ‒ 385–393. DOI: 10.1016/j.iccl.2020.02.009.Solomon R. Hydration: Intravenous and oral: Approaches, principals, and differing regimens: Is it what goes in or what comes out that is important? Interv Cardiol Clin. 2020;9:385–393. DOI: 10.1016/j.iccl.2020.02.009.Steuer J., Bergqvist D., Björck M. Surgical renovascular reconstruction for renal artery stenosis and aneurysm: long-term durability and survival. ‒ European Journal of Vascular and Endovascular Surgery. ‒ 2019. ‒ 57. ‒ 562–568. DOI: 10.1016/j.ejvs.2018.09.014.Steuer J., Bergqvist D., Björck M. Surgical renovascular reconstruction for renal artery stenosis and aneurysm: long-term durability and survival. European Journal of Vascular and Endovascular Surgery. 2019;57:562–568. DOI: 10.1016/j.ejvs.2018.09.014.Kalra P.A., Guo H., Kausz A.T. et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. ‒ Kidney Int. ‒ 2005. ‒ 68. ‒ 293–301. DOI: 10.1111/J.1523-1755.2005.00406.X.Kalra P.A., Guo H., Kausz A.T. et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005; 68:293–301. DOI: 10.1111/J.1523-1755.2005.00406.X.Ritchie J., Green D., Alderson H.V. et al. Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared with other causes of chronic kidney disease. ‒ Nephrology (Carlton). ‒ 2015. ‒ 20. ‒ 688–696. DOI: 10.1111/nep.12501.Ritchie J., Green D., Alderson H.V. et al. Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared with other causes of chronic kidney disease. Nephrology (Carlton). 2015;20:688–696. DOI: 10.1111/nep.12501.Iwashima Y., Ishimitsu T. How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment? ‒ Hypertension Research. ‒ 2020. ‒ 43. ‒ 1015–1027. DOI: 10.1038/s41440-020-0496-z.Iwashima Y., Ishimitsu T. How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment? Hypertension Research. 2020;43:1015–1027. DOI: 10.1038/s41440-020-0496-z.Boateng F.K., Greco B.A. Renal artery stenosis: prevalence of, risk factors for, and management of in-stent stenosis. ‒ Am J Kidney Dis. ‒ 2013. ‒ 61. ‒ 147–160. DOI: 10.1053/J.AJKD.2012.07.025.Boateng F.K., Greco B.A. Renal artery stenosis: prevalence of, risk factors for, and management of in-stent stenosis. Am J Kidney Dis. 2013;61:147–160. DOI: 10.1053/J.AJKD.2012.07.025.Lederman R.J., Mendelsohn F.O., Santos R. et al. Primary renal artery stenting: Characteristics and outcomes after 363 procedures. ‒ Am Heart J. ‒ 2001. ‒ 142. ‒ 314–323. DOI: 10.1067/mhj.2001.116958.Lederman R.J., Mendelsohn F.O., Santos R. et al. Primary renal artery stenting: Characteristics and outcomes after 363 procedures. Am Heart J. 2001;142:314–323. DOI: 10.1067/mhj.2001.116958.Чазова И.Е., Чихладзе Н.М., Блинова Н.В. и др. Евразийские клинические рекомендации по диагностике и лечению вторичных (симптоматических) форм артериальной гипертонии (2022). ‒ Евразийский Кардиологический Журнал. ‒ 2023. ‒ № 1. ‒ С. 6‒65.Chazova I.E., Chikhladze N.M., Blinova N.V. et al. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension. Eurasian Heart J.

The authors declare that there are no conflicts of interest present.